1.
Methods The colouration was used to verify the sudation;
方法 采用着色法 ,观察受试药的发汗作用 ;
2.
An agent, such as a drug, used to treat disease or injury.
药，药物用来治疗疾病或受伤的试剂（如一种药剂）
3.
A Well， if it ha e again， perha you should try Chinese traditional medicine.
A 啊，如果你再难受的话，也许你应该试试中药。
4.
Few Wands of Subjects Protection,Rights and Benefits in Clinical Trials
浅析药物临床试验中对受试者的权益保障
5.
The Body Pharmacokinetic Test of Nefazodone Safety and Tolerance
奈法唑酮安全性、耐受性药动学试验研究
6.
Study on urinary excretion characteristics of eplerenone in healthy volunteers
依普利酮在健康受试者体内的尿药排泄特征
7.
Urine pharmacokinetics of gentiopicroside in healthy volunteers
龙胆苦苷在健康受试者尿中的药代动力学
8.
Study on the Safety Tolerence and Pharmacokinetic of rhGLP-1(7-36) in Chinese Healty Volunteers;
rhGLP-1（7-36）在中国健康受试者中的安全耐受性与药代动力学研究
9.
Medical ethics must be considered for protecting the rights and interests of patients in clinical trials.
为保障受试者的权益药品临床试验必须考虑到医学伦理学问题。
10.
Comparative Study on the Protection of Rights and Interests of Clinical Testees in China and American;
中美药品临床试验受试者权益保障措施的对比研究
11.
Legal Protection of Subjects Informed Consent in Clinical Drug Trials;
浅谈受试者在药物临床试验中知情同意权的法律保护
12.
Beijing anti-AIDS drug clinical trial case and particular protection to vulnerable persons as subjects;
从北京艾滋病药物试验案谈弱势受试人群的特殊保护
13.
The Micromonosporadic Liquid Fertilizer and Experiments Plant on Test with Research
小单孢菌液肥及受试植物的药物残留试验与研究
14.
Analysis of right protection of the subject in the ethical review process of clinical tests of new drugs
新药临床试验伦理审查过程中受试者权益保护的探析
15.
Analysis and Countermeasures of Individual Expulsion in Clinical Drug Trials
药物临床试验中受试者个人原因不依从因素分析及对策
16.
Determination of Emtricitabine Concentration in Human Plasma, Urine and Their Pharmacokinetics Study in Healthy Volunteers;
中国男性健康受试者体内恩曲他滨胶囊的血药、尿药浓度测定和药代动力学研究
17.
Phase Ⅰ Trial of Human Tolerability and Pharmacokinetics to Gambogic Acid;
注射用藤黄酸Ⅰ期临床耐受性及药代动力学试验
18.
Tolerance and Pharmacokinetics Studies of Oral Adefovir Dipivoxil Tablets in Healthy Volunteers;
健康志愿者口服阿德福韦酯片的耐受性试验及药代动力学研究